{"id":"delayed-maintenance-treatment","safety":{"commonSideEffects":[{"rate":"1-5%","effect":"Pneumonitis"},{"rate":"1-5%","effect":"Hypothyroidism"},{"rate":"1-2%","effect":"Hyperthyroidism"},{"rate":"1-2%","effect":"Diarrhea"},{"rate":"1-2%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL7257","moleculeType":"Small molecule","molecularWeight":"218.30"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By binding to the PD-1 receptor, the drug prevents cancer cells from receiving signals that promote their growth and survival. This leads to an increase in the body's immune response against cancer cells, ultimately resulting in their destruction.","oneSentence":"This drug targets the PD-1 receptor to suppress cancer cell growth.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:31:48.899Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-small cell lung cancer, PD-L1 positive"},{"name":"Head and neck squamous cell carcinoma"}]},"trialDetails":[{"nctId":"NCT03811015","phase":"PHASE3","title":"Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-08-16","conditions":"Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":636},{"nctId":"NCT05058651","phase":"PHASE2, PHASE3","title":"Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-06-28","conditions":"Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma, Recurrent Extrapulmonary Neuroendocrine Carcinoma","enrollment":189},{"nctId":"NCT04307576","phase":"PHASE3","title":"A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia","status":"RECRUITING","sponsor":"Mats Heyman","startDate":"2020-07-13","conditions":"Leukemia, Acute Lymphoblastic","enrollment":6430},{"nctId":"NCT02615184","phase":"PHASE2","title":"A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old","status":"ACTIVE_NOT_RECRUITING","sponsor":"Takeda","startDate":"2023-05-23","conditions":"Erosive Esophagitis","enrollment":76},{"nctId":"NCT07200102","phase":"PHASE1","title":"Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-03-17","conditions":"Multiple Myeloma","enrollment":20},{"nctId":"NCT05140421","phase":"NA","title":"Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program","status":"ACTIVE_NOT_RECRUITING","sponsor":"City University of New York","startDate":"2021-12-15","conditions":"Hiv","enrollment":1494},{"nctId":"NCT05681260","phase":"PHASE3","title":"Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)","status":"RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2023-02-06","conditions":"T-cell Lymphoblastic Lymphoma","enrollment":200},{"nctId":"NCT07190404","phase":"NA","title":"Multicontext Approach for Cognitive Function in Parkinson Disease","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-04-22","conditions":"PARKINSON DISEASE (Disorder)","enrollment":114},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT04789733","phase":"NA","title":"The GUARDIAN Pilot Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-04-27","conditions":"General Surgery","enrollment":80},{"nctId":"NCT02114229","phase":"PHASE2","title":"Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2014-05-14","conditions":"Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor","enrollment":125},{"nctId":"NCT04378439","phase":"NA","title":"Appalachian Partnership to Reduce Disparities (Aim 2)","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2022-04-01","conditions":"HIV/AIDS, STI, HCV","enrollment":141},{"nctId":"NCT04959019","phase":"NA","title":"Exercise for Memory Rehabilitation in Epilepsy","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2021-07-21","conditions":"Epilepsy, Generalized, Memory Impairment","enrollment":71},{"nctId":"NCT07461844","phase":"NA","title":"Transdiagnostic Sleep and Circadian Treatment for Autistic Adults","status":"NOT_YET_RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2026-09-01","conditions":"Sleep, Autism Spectrum Disorder, Transdiagnostic","enrollment":24},{"nctId":"NCT07454226","phase":"NA","title":"ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Ph-Like, Acute Lymphoblastic Leukemia","enrollment":30},{"nctId":"NCT05681195","phase":"PHASE2","title":"Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas","status":"RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2024-04-25","conditions":"Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma, Relapsed Cancer","enrollment":15},{"nctId":"NCT07443592","phase":"NA","title":"Treatment for Ph-negative ALL for Adults up to 65 Years","status":"NOT_YET_RECRUITING","sponsor":"PETHEMA Foundation","startDate":"2026-03-06","conditions":"Acute Lymphoblastic Leukemia","enrollment":330},{"nctId":"NCT06055608","phase":"PHASE2","title":"Advancing Transplantation Outcomes in Children","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-05-22","conditions":"Kidney Transplant","enrollment":200},{"nctId":"NCT03150693","phase":"PHASE3","title":"Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia","status":"SUSPENDED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2017-09-20","conditions":"B Acute Lymphoblastic Leukemia","enrollment":310},{"nctId":"NCT07277621","phase":"NA","title":"Behavioral Interventions to Reduce Social Media Addiction Among School-Going Adolescents in Karachi","status":"COMPLETED","sponsor":"Dow University of Health Sciences","startDate":"2025-10-10","conditions":"Internet Addiction Disorder","enrollment":260},{"nctId":"NCT04817761","phase":"PHASE2, PHASE3","title":"SPARK-ALL: Calaspargase Pegol in Adults With ALL","status":"TERMINATED","sponsor":"Institut de Recherches Internationales Servier","startDate":"2021-07-07","conditions":"Acute Lymphoblastic Leukemia","enrollment":42},{"nctId":"NCT05225961","phase":"PHASE4","title":"ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-05-01","conditions":"Acute Ischemic Stroke","enrollment":240},{"nctId":"NCT07146451","phase":"","title":"6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 Weeks","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-10-28","conditions":"Children Born to Mothers Enrolled in the TOCOPROM Trial","enrollment":480},{"nctId":"NCT07215273","phase":"PHASE2","title":"Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections","status":"RECRUITING","sponsor":"Elion Therapeutics, Inc.","startDate":"2026-02","conditions":"Suspected Invasive Mould Infection","enrollment":80},{"nctId":"NCT07282951","phase":"NA","title":"Strong Evidence: Digitally Delivered Exercise in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Diego","startDate":"2026-02-15","conditions":"Fall Prevention, Fall Prevention in Healthy Aging","enrollment":60},{"nctId":"NCT00602667","phase":"PHASE2","title":"Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2007-12-17","conditions":"Brain and Central Nervous System Tumors","enrollment":293},{"nctId":"NCT03571321","phase":"PHASE1","title":"Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2019-05-28","conditions":"Acute Lymphoblastic Leukemia, ALL, Childhood, ALL","enrollment":15},{"nctId":"NCT01757626","phase":"PHASE1, PHASE2","title":"Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-12","conditions":"Neuroblastoma","enrollment":186},{"nctId":"NCT05993481","phase":"NA","title":"The Noninvasive Blood Pressure Measurement Effect on the Hypotension","status":"ENROLLING_BY_INVITATION","sponsor":"Konya City Hospital","startDate":"2024-10-25","conditions":"Hypotension During Surgery","enrollment":640},{"nctId":"NCT01871766","phase":"PHASE2","title":"Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-12-04","conditions":"Rhabdomyosarcoma","enrollment":115},{"nctId":"NCT06433635","phase":"PHASE4","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-10-01","conditions":"Bipolar I Disorder, Depression","enrollment":2726},{"nctId":"NCT07284511","phase":"PHASE2, PHASE3","title":"A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar","status":"NOT_YET_RECRUITING","sponsor":"Melissa-Rosina Pasqua","startDate":"2026-01-05","conditions":"Type 1 Diabetes, Type 1 Diabetes Mellitus, T1D","enrollment":105},{"nctId":"NCT02754583","phase":"PHASE3","title":"Sanitation, Water, and Instruction in Face-washing for Trachoma I/II","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-12-05","conditions":"Trachoma","enrollment":47605},{"nctId":"NCT07233668","phase":"NA","title":"Immediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCC","status":"NOT_YET_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2025-12-01","conditions":"Metastatic Renal Cell Carcinoma ( mRCC)","enrollment":172},{"nctId":"NCT07257016","phase":"NA","title":"HFTO Via Tracheal Intubation in Neurocritical Patients","status":"NOT_YET_RECRUITING","sponsor":"Capital Medical University","startDate":"2025-12-01","conditions":"High Flow Oxygen Therapy, Neuro ICU","enrollment":28},{"nctId":"NCT02883049","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2012-02-29","conditions":"B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Central Nervous System Leukemia","enrollment":5949},{"nctId":"NCT07224646","phase":"NA","title":"Whole-Body Photobiomodulation Use in Professional Soccer Players During a State Championship","status":"RECRUITING","sponsor":"Universidade Federal de Sao Carlos","startDate":"2025-09-04","conditions":"Athletic Performance, Muscle Fatigue, Muscle Strength","enrollment":24},{"nctId":"NCT07235514","phase":"NA","title":"Anesthesia Management in Endovascular Therapy for Ischemic Stroke - 2","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2025-12-01","conditions":"Ischemic Stroke, Anterior Cerebral Circulation, General Anesthesia","enrollment":958},{"nctId":"NCT07233512","phase":"NA","title":"EFFECT OF PERIODONTAL TREATMENT ON ALZHEIMER DISEASE-ASSOCIATED OUTCOMES","status":"ENROLLING_BY_INVITATION","sponsor":"Centre Hospitalier Universitaire de Liege","startDate":"2023-11-17","conditions":"Alzheimers Disease, Periodontitis","enrollment":26},{"nctId":"NCT03524092","phase":"PHASE3","title":"A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2018-10-19","conditions":"Ulcerative Colitis","enrollment":1177},{"nctId":"NCT05205512","phase":"NA","title":"Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS Trial","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2022-09-14","conditions":"Hodgkin Lymphoma, Non-Hodgkin Lymphoma","enrollment":10},{"nctId":"NCT04012073","phase":"PHASE3","title":"Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome","status":"TERMINATED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2022-11-01","conditions":"Respiratory Distress Syndrome, Adult","enrollment":18},{"nctId":"NCT07190027","phase":"PHASE1, PHASE2","title":"Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2025-11","conditions":"Advanced Non-Small Cell Lung Cancer (NSCLC)","enrollment":246},{"nctId":"NCT06840782","phase":"PHASE3","title":"First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2025-09-09","conditions":"Oligometastatic Non-small Cell Lung Cancer (NSCLC)","enrollment":124},{"nctId":"NCT06051890","phase":"PHASE4","title":"Assessing Optimal XRB Initiation Points in Jail","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2025-06-02","conditions":"Opioid Use Disorder","enrollment":200},{"nctId":"NCT07149922","phase":"NA","title":"Early Blood Pressure Intervention After Coiling or Clipping for Subarachnoid Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-08-31","conditions":"Aneurysmal Subarachnoid Hemorrhage, Aneurysmal Subarachnoid Hemorrhage (aSAH)","enrollment":750},{"nctId":"NCT07108530","phase":"PHASE2","title":"Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-08-06","conditions":"Acute Myeloid Leukemia","enrollment":50},{"nctId":"NCT06942494","phase":"NA","title":"Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD","status":"RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2025-04-30","conditions":"Obsessive - Compulsive Disorder","enrollment":88},{"nctId":"NCT04647760","phase":"NA","title":"Packaging and Disseminating the JOIN for ME Program in Low-Income Settings","status":"COMPLETED","sponsor":"The Miriam Hospital","startDate":"2021-01-25","conditions":"Pediatric Obesity","enrollment":111},{"nctId":"NCT07059156","phase":"PHASE2, PHASE3","title":"Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-06-01","conditions":"Acute Lymphoblastic Leukemia, Adult","enrollment":50},{"nctId":"NCT03977571","phase":"NA","title":"Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial","status":"RECRUITING","sponsor":"Niels Fristrup","startDate":"2020-07-06","conditions":"Kidney Cancer, Renal Cell Carcinoma Metastatic, Synchronous Neoplasm","enrollment":400},{"nctId":"NCT06771843","phase":"NA","title":"Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments","status":"RECRUITING","sponsor":"San Diego State University","startDate":"2025-06-16","conditions":"HIV Antiretroviral Therapy (ART) Adherence, Alcohol Abuse, HIV Infection","enrollment":716},{"nctId":"NCT05617963","phase":"PHASE2","title":"Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax","status":"RECRUITING","sponsor":"UNICANCER","startDate":"2023-03-24","conditions":"Small Cell Lung Carcinoma","enrollment":100},{"nctId":"NCT06890143","phase":"PHASE3","title":"The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2025-03-22","conditions":"Pediatric Hereditary Kidney Diseases","enrollment":44},{"nctId":"NCT06099366","phase":"PHASE2","title":"Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children","status":"RECRUITING","sponsor":"Hee Young Ju","startDate":"2024-03-05","conditions":"Lymphoblastic Leukemia in Children","enrollment":116},{"nctId":"NCT05468437","phase":"NA","title":"Telenutrition for Individuals With SCI","status":"RECRUITING","sponsor":"Santa Clara Valley Health & Hospital System","startDate":"2022-06-13","conditions":"Spinal Cord Injuries, Obesity, Cardiometabolic Syndrome","enrollment":96},{"nctId":"NCT06295276","phase":"NA","title":"Effect of Teletherapy-supported Training on Nursing Students","status":"COMPLETED","sponsor":"Hochschule Osnabruck","startDate":"2024-01-31","conditions":"Low Back Pain, Neck Pain","enrollment":48},{"nctId":"NCT00317720","phase":"PHASE1, PHASE2","title":"Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-04","conditions":"Breast Cancer, Neoplasm Metastasis","enrollment":40},{"nctId":"NCT02407236","phase":"PHASE3","title":"A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-07-10","conditions":"Colitis, Ulcerative, Inflammatory Bowel Diseases","enrollment":961},{"nctId":"NCT06938789","phase":"NA","title":"How Bleeding Affects Delirium in Older Patients With Hip Fractures: The IMPROVE-HIP Study","status":"NOT_YET_RECRUITING","sponsor":"University of Aarhus","startDate":"2025-04","conditions":"Bleeding, Hip Fracture, Delirium - Postoperative","enrollment":198},{"nctId":"NCT00408005","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2007-01-30","conditions":"T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma","enrollment":1895},{"nctId":"NCT05684276","phase":"PHASE2","title":"DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors","status":"RECRUITING","sponsor":"Fundación GECP","startDate":"2023-05-12","conditions":"NSCLC, Pancoast Tumor","enrollment":22},{"nctId":"NCT04564157","phase":"PHASE3","title":"New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación GECP","startDate":"2021-01-13","conditions":"Non-Small Cell Lung Cancer, Adjuvant Chemotherapy","enrollment":210},{"nctId":"NCT06918184","phase":"NA","title":"Timing of Specific Exercise Therapy After Breast Cancer Surgery: Early Versus Delayed Initiation","status":"RECRUITING","sponsor":"Al Hayah University In Cairo","startDate":"2025-04-15","conditions":"Breast Cancer","enrollment":140},{"nctId":"NCT01190930","phase":"PHASE3","title":"Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2010-08-09","conditions":"Acute Lymphoblastic Leukemia, Adult B Lymphoblastic Lymphoma, Ann Arbor Stage I B Lymphoblastic Lymphoma","enrollment":9350},{"nctId":"NCT03305549","phase":"NA","title":"Recovery After Dialysis-Requiring Acute Kidney Injury","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2017-09-29","conditions":"Acute Kidney Injury","enrollment":16},{"nctId":"NCT06855316","phase":"NA","title":"Evaluating Combined Electromagnetic Stimulation for Enhanced Physical and Psychological Recovery in Athletes with DOMS","status":"NOT_YET_RECRUITING","sponsor":"Sierra Varona SL","startDate":"2025-02-24","conditions":"Recovery, Psychological, Transcranial Magnetic Stimulation","enrollment":48},{"nctId":"NCT06851247","phase":"PHASE2","title":"GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-01-03","conditions":"Nasopharyngeal Carcinoma","enrollment":47},{"nctId":"NCT05637177","phase":"NA","title":"Preventive Intervention to Promote Healthy Ageing","status":"COMPLETED","sponsor":"University of Ostrava","startDate":"2022-01-01","conditions":"Preventive Intervention","enrollment":200},{"nctId":"NCT04968119","phase":"NA","title":"Telehealth Exercise Platform to Reduce Frailty After Bone Marrow Transplant","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2021-07-12","conditions":"Hematopoietic and Lymphoid Cell Neoplasm","enrollment":21},{"nctId":"NCT06246734","phase":"NA","title":"Companion Robotic Pets and Older Adults","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2024-03-03","conditions":"Dementia, Social Behavior, Caregiver Burden","enrollment":53},{"nctId":"NCT01744782","phase":"PHASE3","title":"Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis","status":"COMPLETED","sponsor":"Amgen","startDate":"2012-12-20","conditions":"Cystinosis","enrollment":17},{"nctId":"NCT01725165","phase":"PHASE2","title":"Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-11-28","conditions":"Recurrent Lung Non-Small Cell Carcinoma, Stage IV Non-Small Cell Lung Cancer AJCC v7","enrollment":85},{"nctId":"NCT05623137","phase":"NA","title":"Acu-TENS to Improve the Sleep Quality in People with Stroke","status":"RECRUITING","sponsor":"The Hong Kong Polytechnic University","startDate":"2022-12-01","conditions":"AcuTENS, Sleep Quality, Stroke","enrollment":70},{"nctId":"NCT04796506","phase":"NA","title":"Slow Wave Sleep As a Biomarker of Rehabilitation-induced Cognitive Improvement in PD","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2021-07-01","conditions":"Parkinson Disease","enrollment":120},{"nctId":"NCT05468372","phase":"PHASE2","title":"Amphotericin Versus Posaconazole for Pulmonary Mucormycosis","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2022-07-01","conditions":"Mucormycosis; Pulmonary (Etiology)","enrollment":50},{"nctId":"NCT04377087","phase":"PHASE2","title":"Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer","status":"TERMINATED","sponsor":"Sarah E Taylor","startDate":"2020-06-29","conditions":"Ovarian Cancer","enrollment":3},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06096740","phase":"NA","title":"Psychotherapy Effects on Reward Processing in PTSD","status":"RECRUITING","sponsor":"University of Texas at Austin","startDate":"2024-06-01","conditions":"Post Traumatic Stress Disorder, Diminished Pleasure, Anhedonia","enrollment":120},{"nctId":"NCT03972891","phase":"NA","title":"Influence - Intervention Break - Children - Speech Sound Disorders","status":"WITHDRAWN","sponsor":"University of Applied Sciences for Health Professions Upper Austria","startDate":"2024-02","conditions":"Speech Sound Disorder","enrollment":""},{"nctId":"NCT04632043","phase":"NA","title":"Early Versus Delayed Intubation of Patients With COVID-19","status":"TERMINATED","sponsor":"Evangelismos Hospital","startDate":"2020-11-18","conditions":"COVID-19, Acute Hypoxemic Respiratory Failure","enrollment":2},{"nctId":"NCT05867576","phase":"NA","title":"Acceptance and Commitment Therapy in Tuberous Sclerosis Complex","status":"UNKNOWN","sponsor":"University Hospitals Bristol and Weston NHS Foundation Trust","startDate":"2021-08-12","conditions":"Tuberous Sclerosis Complex","enrollment":15},{"nctId":"NCT01995708","phase":"PHASE1","title":"CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2014-01-31","conditions":"Multiple Myeloma","enrollment":28},{"nctId":"NCT03824769","phase":"NA","title":"Physical Activity Choices Everyday","status":"COMPLETED","sponsor":"University of Connecticut","startDate":"2019-03-11","conditions":"Obesity","enrollment":160},{"nctId":"NCT03538691","phase":"PHASE3","title":"A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2018-07-13","conditions":"Major Depressive Disorder","enrollment":1149},{"nctId":"NCT03784443","phase":"PHASE2, PHASE3","title":"Combined Ranibizumab and Iluvien for Diabetic Macular Oedema","status":"WITHDRAWN","sponsor":"Imperial College London","startDate":"2019-09-01","conditions":"Diabetic Macular Edema, Diabetes","enrollment":""},{"nctId":"NCT05410288","phase":"NA","title":"Acu-TENS and Acupressure on the Sleep Quality","status":"COMPLETED","sponsor":"The Hong Kong Polytechnic University","startDate":"2022-06-01","conditions":"acuTENS, Sleep Quality, Insomnia","enrollment":76},{"nctId":"NCT00556933","phase":"PHASE4","title":"Improved Induction and Maintenance Immunosuppression in Kidney Transplantation","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2004-04-01","conditions":"End-stage Renal Disease","enrollment":180},{"nctId":"NCT03479554","phase":"PHASE3","title":"China Antihypertensive Trial in Acute Ischemic Stroke II","status":"COMPLETED","sponsor":"Tulane University","startDate":"2018-06-13","conditions":"Acute Ischemic Stroke","enrollment":4810},{"nctId":"NCT05818267","phase":"NA","title":"Efficacy and Safety of Regorafenib Maintenance Therapy in Patients With Metastatic Colorectal Cancer (mCRC)","status":"UNKNOWN","sponsor":"Wei Zhang","startDate":"2023-06-26","conditions":"Colorectal Cancer","enrollment":30},{"nctId":"NCT05753839","phase":"NA","title":"The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2023-07","conditions":"Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Neoplasm","enrollment":40},{"nctId":"NCT05445505","phase":"NA","title":"Neuroprotective Effects of iTBS in PD","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2022-08-01","conditions":"Neuroprotection, Parkinson Disease, Intermittent Theta Burst Stimulation","enrollment":60},{"nctId":"NCT02756507","phase":"NA","title":"Transdiagnostic REBT Prevention Program for Adolescents","status":"COMPLETED","sponsor":"Babes-Bolyai University","startDate":"2016-06","conditions":"Social Anxiety, Major Depression Mild, Panic Disorder","enrollment":381},{"nctId":"NCT03712137","phase":"PHASE3","title":"Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition","status":"COMPLETED","sponsor":"Allergan","startDate":"2018-11-12","conditions":"Jawline Definition","enrollment":206},{"nctId":"NCT02649439","phase":"PHASE2","title":"Prostvac in Patients With Biochemically Recurrent Prostate Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2015-12-22","conditions":"Prostate Cancer","enrollment":97},{"nctId":"NCT03542461","phase":"PHASE3","title":"Early Switch Maintenance vs Delayed Second-line Nivolumab in Advanced Stage Squamous Non-small Cell Lung Cancer (NSCLC) Patients (EDEN Trial)","status":"UNKNOWN","sponsor":"Gruppo Oncologico Italiano di Ricerca Clinica","startDate":"2017-09-25","conditions":"Squamous Non-small Cell Lung Cancer","enrollment":125},{"nctId":"NCT03226301","phase":"PHASE2","title":"A Prospective, Multicenter, Phase-II Trial of Ibrutinib Plus Venetoclax in Patients With Creatinine Clearance >= 30 ml/Min Who Have Relapsed or Refractory Chronic Lymphocytic Leukemia (RR-CLL) With or Without TP53 Aberrations","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stichting Hemato-Oncologie voor Volwassenen Nederland","startDate":"2017-06-23","conditions":"Chronic Lymphocytic Leukemia in Relapse, Chronic Lymphocytic Leukemia in Remission","enrollment":230},{"nctId":"NCT03025139","phase":"NA","title":"Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)","status":"UNKNOWN","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2017-02-20","conditions":"Cancer Survivor, Early-Stage Breast Carcinoma, Stage 0 Breast Cancer","enrollment":96},{"nctId":"NCT03434704","phase":"PHASE2","title":"Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole","status":"COMPLETED","sponsor":"Ciceri Fabio","startDate":"2018-06-18","conditions":"Transplant-Related Hematologic Malignancy, Leukemia, Acute, Myelodysplastic Syndromes","enrollment":10},{"nctId":"NCT04179929","phase":"NA","title":"Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults","status":"RECRUITING","sponsor":"PETHEMA Foundation","startDate":"2019-11-25","conditions":"Acute Lymphoblastic Leukemia","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":562,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Delayed Maintenance treatment","genericName":"Delayed Maintenance treatment","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug targets the PD-1 receptor to suppress cancer cell growth. Used for Non-small cell lung cancer, PD-L1 positive, Head and neck squamous cell carcinoma.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}